Info 4 the sidelines, page-2

Afnanny,

1. About 80M shares on issue.

2. Yes- Directors have equity and are strongly committed to the Company

3. After successful human trials, it typically takes around 12 months to obtain marketing approval. Following this, the drug will be launched into the market within 3-6 months. a number of trials are required to obtain approval and this process will take a few years.
However, it is most likely the drug will be licensed to a Pharma partner following positive data in a Phase 2a study. Of course, it could even be partnered following phase 1 (which will compete in 2021) or later after phase 2b if the company prefers to develop it further and take a bigger share on signing the licensing deal.

Certainly has a lot of potential upside...